It has been reported that estradiol deprivation [22] or treatments with selective estrogen receptor modulators (SERMs) [23-26], antagonists of estrogen receptor [27] or aromatase inhibitors [28] induce inhibition of cell proliferation and apoptosis in breast cancer cells. This evidence concerns the gene CYP19A1 and breast cancer.